Literature DB >> 10882368

X-Ray structure of cytotoxic trans-[PtCl(2)(dimethylamine)(isopropylamine)]: interstrand cross-link efficiency, DNA sequence specificity, and inhibition of the B-Z transition.

J M Pérez1, E I Montero, A M González, X Solans, M Font-Bardia, M A Fuertes, C Alonso, C Navarro-Ranninger.   

Abstract

We report here the X-ray structure of cytotoxic trans-¿PtCl(2)(dimethylamine)(isopropylamine). This trans-platinum compound crystallizes in the monoclinic system, with Z = 8, in the spatial group C2/c with unit cell parameters a = 19.862(17) A, b = 6. 581(3) A, c = 18.563(3) A, alpha = 90 degrees, beta = 119.16(3) degrees, gamma = 90 degrees, V = 2119(2) A(3), rho = 2.321 Mg/m(3), R = 0.0505, and R(w) = 0.1166 on the basis of 2339 independent reflections. To our knowledge this is the first report of the crystal structure of a biologically active trans-platinum compound containing different aliphatic amines. The DNA binding mode of trans-¿PtCl(2)(dimethylamine)(isopropylamine) may be a consequence of the spatial disposition of the dimethylamine and isopropylamine ligands around the trans-Pt(II) center. We have found that trans-¿PtCl(2)(dimethylamine)(isopropylamine) readily forms DNA interstrand cross-links. In addition, the compound shows binding affinity toward alternating purine-pyrimidine sequences and inhibits the B-Z transition. These particular DNA binding properties might be related to the capacity of trans-¿PtCl(2)(dimethylamine)(isopropylamine) for inducing some selective killing in a H-ras overexpresssing cell line.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10882368     DOI: 10.1021/jm000925p

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  5 in total

1.  Proteins as possible targets for cytotoxic trans-platinum(II) complexes with aliphatic amine ligands: Further exceptions to the DNA paradigm.

Authors:  Leticia Cubo; Michael Groessl; Paul J Dyson; Adoración G Quiroga; Carmen Navarro-Ranninger; Angela Casini
Journal:  ChemMedChem       Date:  2010-08-02       Impact factor: 3.466

2.  Cellular accumulation and DNA interaction studies of cytotoxic trans-platinum anticancer compounds.

Authors:  Caroline Bartel; Anna K Bytzek; Yulia Yu Scaffidi-Domianello; Gerlinde Grabmann; Michael A Jakupec; Christian G Hartinger; Markus Galanski; Bernhard K Keppler
Journal:  J Biol Inorg Chem       Date:  2012-01-07       Impact factor: 3.862

3.  Biological evaluation of transdichloridoplatinum(II) complexes with 3- and 4-acetylpyridine in comparison to cisplatin.

Authors:  Lana Filipovic; Sandra Arandelovic; Nevenka Gligorijevic; Ana Krivokuca; Radmila Jankovic; Tatjana Srdic-Rajic; Gordana Rakic; Zivoslav Tesic; Sinisa Radulovic
Journal:  Radiol Oncol       Date:  2013-10-08       Impact factor: 2.991

4.  Trans-platinum(II) complexes with cyclohexylamine as expectator ligand induce necrosis in tumour cells by inhibiting DNA synthesis and RNA transcription.

Authors:  V Cepero; B García-Serrelde; V Moneo; F Blanco; A M González-Vadillo; A Alvarez-Valdés; C Navarro-Ranninger; A Carnero
Journal:  Clin Transl Oncol       Date:  2007-08       Impact factor: 3.340

5.  New Findings in the Signaling Pathways of cis and trans Platinum Iodido Complexes' Interaction with DNA of Cancer Cells.

Authors:  Adoración G Quiroga; Marta Cama; Natalia Pajuelo-Lozano; Amparo Álvarez-Valdés; Isabel Sanchez Perez
Journal:  ACS Omega       Date:  2019-12-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.